Arterial thromboembolic complications in COVID-19 in low-risk patients despite prophylaxis.
作者信息
Griffin Daniel O, Jensen Alexandra, Khan Mushmoom, Chin Jessica, Chin Kelly, Parnell Ryan, Awwad Christopher, Patel Darshan
机构信息
Department of Biochemistry and Molecular Biophysics, Columbia University Medical Center, New York, NY, USA.
Division of Infectious Diseases, Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
出版信息
Br J Haematol. 2020 Jul;190(1):e11-e13. doi: 10.1111/bjh.16792. Epub 2020 May 28.
Abstract
摘要
相似文献
1
Arterial thromboembolic complications in COVID-19 in low-risk patients despite prophylaxis.尽管采取了预防措施，但新冠病毒疾病（COVID-19）低风险患者仍出现动脉血栓栓塞并发症。
Br J Haematol. 2020 Jul;190(1):e11-e13. doi: 10.1111/bjh.16792. Epub 2020 May 28.
2
Venous thromboembolism in patients with COVID-19 (SARS-CoV-2 infection) - a position paper of the German Society of Angiology (DGA).2019冠状病毒病（SARS-CoV-2感染）患者的静脉血栓栓塞——德国血管病学会（DGA）立场文件
Vasa. 2020 Jun;49(4):259-263. doi: 10.1024/0301-1526/a000885. Epub 2020 Jun 5.
3
[Late occurrence of pulmonary embolsim in SARS-CoV-2 pneumonia: a case series].[新型冠状病毒肺炎中肺栓塞的晚期发生：病例系列]
G Ital Cardiol (Rome). 2020 Jul;21(7):523-525. doi: 10.1714/3386.33638.
4
Mechanisms of stroke and the role of anticoagulants in COVID-19.中风的机制及抗凝剂在新型冠状病毒肺炎中的作用
J Formos Med Assoc. 2020 Nov;119(11):1721-1722. doi: 10.1016/j.jfma.2020.06.026. Epub 2020 Jun 26.
5
COVID-19 and venous thromboembolism - prophylaxis and treatment.新型冠状病毒肺炎与静脉血栓栓塞症——预防与治疗
Tidsskr Nor Laegeforen. 2020 Jun 17;140(11). doi: 10.4045/tidsskr.20.0440. Print 2020 Aug 18.
6
Malignant Cerebral Ischemia in A COVID-19 Infected Patient: Case Review and Histopathological Findings.COVID-19 感染患者的恶性大脑缺血：病例回顾与组织病理学发现。
J Stroke Cerebrovasc Dis. 2020 Nov;29(11):105231. doi: 10.1016/j.jstrokecerebrovasdis.2020.105231. Epub 2020 Aug 5.
7
How to face cancer treatment in the COVID-19 era.在新冠疫情时代如何面对癌症治疗
Expert Rev Anticancer Ther. 2020 Jun;20(6):429-432. doi: 10.1080/14737140.2020.1766355. Epub 2020 May 18.
8
Registry of Arterial and Venous Thromboembolic Complications in Patients With COVID-19.COVID-19 患者的动脉和静脉血栓栓塞并发症登记册。
J Am Coll Cardiol. 2020 Nov 3;76(18):2060-2072. doi: 10.1016/j.jacc.2020.08.070.
9
What is COVID-19?什么是新冠病毒？
Pediatr Dermatol. 2020 May;37(3):555-556. doi: 10.1111/pde.14218.
10
How to Protect Older Adults With Comorbidities During Phase 2 of the COVID-19 Pandemic: Nurses' Contributions.如何在新冠疫情第二阶段保护患有合并症的老年人：护士的贡献
J Gerontol Nurs. 2020 Sep 1;46(9):7-8. doi: 10.3928/00989134-20200811-02.
引用本文的文献
1
Postacute Sequelae of COVID (PASC or Long COVID): An Evidenced-Based Approach.新冠后遗症（PASC 或长期新冠）：基于证据的方法。
Open Forum Infect Dis. 2024 Aug 27;11(9):ofae462. doi: 10.1093/ofid/ofae462. eCollection 2024 Sep.
2
Acute limb ischemia in COVID-19 patients despite therapeutic anticoagulation: Experience from Africa.尽管进行了抗凝治疗，但新冠病毒感染患者出现急性肢体缺血：来自非洲的经验。
Thromb Update. 2023 Mar;10:100128. doi: 10.1016/j.tru.2022.100128. Epub 2022 Dec 30.
3
Pulmonary Thrombosis despite Therapeutic Anticoagulation in COVID-19 Pneumonia: A Case Report and Literature Review.COVID-19 肺炎治疗性抗凝后发生肺血栓栓塞症：病例报告及文献复习。
Viruses. 2023 Jul 12;15(7):1535. doi: 10.3390/v15071535.
4
Comparative highlights on MERS-CoV, SARS-CoV-1, SARS-CoV-2, and NEO-CoV.中东呼吸综合征冠状病毒、严重急性呼吸综合征冠状病毒1型、严重急性呼吸综合征冠状病毒2型和新冠状病毒的比较要点。
EXCLI J. 2022 Sep 29;21:1245-1272. doi: 10.17179/excli2022-5355. eCollection 2022.
5
Effect of low dose acetylsalicylic acid and anticoagulant on clinical outcomes in COVID-19, analytical cross-sectional study.低剂量乙酰水杨酸和抗凝剂对新型冠状病毒肺炎临床结局的影响，分析性横断面研究
Health Sci Rep. 2022 Jul 11;5(4):e699. doi: 10.1002/hsr2.699. eCollection 2022 Jul.
6
Clinical features of thrombosis and bleeding in COVID-19.新型冠状病毒肺炎患者的血栓形成和出血的临床特征。
Blood. 2022 Jul 21;140(3):184-195. doi: 10.1182/blood.2021012247.
7
Heparin-Induced Thrombocytopenia in COVID-19: A Systematic Review.新型冠状病毒肺炎中的肝素诱导的血小板减少症：一项系统评价
Anesth Essays Res. 2021 Oct-Dec;15(4):341-347. doi: 10.4103/aer.aer_151_21. Epub 2022 Mar 8.
8
Aortic thrombosis associated with COVID 19 pneumonia.与 COVID-19 肺炎相关的主动脉血栓。
Tunis Med. 2021;99(10):1000-1002.
9
Clinical Applications of Aspirin as a Multi-potent Drug Beyond Cardiovascular Implications: A Proof of Concept for Anesthesiologists- A Narrative Review.阿司匹林作为一种具有多种功效的药物在心血管疾病以外领域的临床应用：麻醉医生的概念验证——一篇叙述性综述
Anesth Pain Med. 2021 Oct 31;11(5):e118909. doi: 10.5812/aapm.118909. eCollection 2021 Oct.
10
Clotting events among hospitalized patients infected with COVID-19 in a large multisite cohort in the United States.美国大型多地点队列中 COVID-19 住院患者的血栓事件。
PLoS One. 2022 Jan 5;17(1):e0262352. doi: 10.1371/journal.pone.0262352. eCollection 2022.
本文引用的文献
1
Pulmonary Embolism and Increased Levels of d-Dimer in Patients with Coronavirus Disease.新型冠状病毒病患者的肺栓塞与 d-二聚体水平升高。
Emerg Infect Dis. 2020 Aug;26(8):1941-1943. doi: 10.3201/eid2608.201477. Epub 2020 Apr 29.
2
Diagnosis, Prevention, and Treatment of Thromboembolic Complications in COVID-19: Report of the National Institute for Public Health of the Netherlands.新型冠状病毒肺炎相关血栓栓塞性并发症的诊断、预防和治疗：荷兰国家公共卫生研究所报告。
Radiology. 2020 Oct;297(1):E216-E222. doi: 10.1148/radiol.2020201629. Epub 2020 Apr 23.
3
High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients.抗凝治疗的重症 COVID-19 患者中静脉血栓栓塞事件发生率高。
J Thromb Haemost. 2020 Jul;18(7):1743-1746. doi: 10.1111/jth.14869. Epub 2020 May 27.
4
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review.新型冠状病毒肺炎与血栓栓塞性疾病：预防、抗栓治疗与随访的相关问题：美国心脏病学会临床实践更新。
J Am Coll Cardiol. 2020 Jun 16;75(23):2950-2973. doi: 10.1016/j.jacc.2020.04.031. Epub 2020 Apr 17.
5
Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action.新型冠状病毒肺炎患者的血栓栓塞风险和抗凝治疗：新出现的证据和行动呼吁。
Br J Haematol. 2020 Jun;189(5):846-847. doi: 10.1111/bjh.16727. Epub 2020 May 4.
6
Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality.严重 COVID-19 中的细胞因子释放综合征：白细胞介素-6 受体拮抗剂托珠单抗可能是降低死亡率的关键。
Int J Antimicrob Agents. 2020 May;55(5):105954. doi: 10.1016/j.ijantimicag.2020.105954. Epub 2020 Mar 29.
7
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
8
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
9
Thrombosis and platelets: an update.血栓形成与血小板：最新进展
Eur Heart J. 2017 Mar 14;38(11):785-791. doi: 10.1093/eurheartj/ehw550.
10
New insights into the mechanisms of action of aspirin and its use in the prevention and treatment of arterial and venous thromboembolism.阿司匹林作用机制的新见解及其在动脉和静脉血栓栓塞预防和治疗中的应用。
Ther Clin Risk Manag. 2015 Sep 24;11:1449-56. doi: 10.2147/TCRM.S92222. eCollection 2015.
Zotero 插件